Search

everythinglearnresearchcommunity

for

Search:↓

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Higher sebum levels are linked to more severe male baldness.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

Rothmund-Thomson syndrome type 2 can cause chronic, poorly healing wounds.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

The authors suggest using a standard system to name hair grafts to improve communication in hair restoration.

Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Hair transplantation has evolved to refined techniques like FUE and FUT, with Finasteride and Minoxidil as the only other proven treatments for hair loss.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Receding hairlines in men are uneven, with the right side larger than the left.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

58% of men aged 30-50 have hair loss, with severity increasing with age.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Cyclosporin doesn't stop hair loss.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Platelet-rich plasma treatment significantly increased hair diameter and density, stopped hair fall, and boosted hair growth in men with hair loss, with no reported side effects.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.